Skip to main content
Log in

Quantitative assessment of terminal ileum motility on MR enterography in Crohn disease: a feasibility study in children

  • Paediatric
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

Investigate the relationship between quantified terminal ileal (TI) motility and histopathological activity grading, Crohn Disease MRI Index (CDMI) and faecal calprotectin.

Methods

Retrospective review of children with Crohn disease or unclassified inflammatory bowel disease, who underwent MR enterography. Dynamic imaging for 25 patients (median age 12, range 5 to 16) was analysed with a validated motility algorithm. The TI motility score was derived. The primary reference standard was TI Endoscopic biopsy Assessment of Inflammatory Activity (eAIS) within 40 days of the MR enterography. Secondary reference standards: (1) the Crohn Disease MRI Index (CDMI) and (2) faecal calprotectin levels.

Results

MR enterography median motility score was 0.17 a.u. (IQR 0.12 to 0.25; range 0.05 to 0.55), and median CDMI was 3 (IQR 0 to 5.5). Forty-three percent of patients had active disease (eAIS > 0) with a median eAIS score of 0 (IQR 0 to 2; range 0 to 5). The correlation between eAIS and motility was r = − 0.58 (p = 0.004, N = 23). Between CDMI and motility, r = − 0.42 (p = 0.037, N = 25). Motility score was lower in active disease (median 0.12 vs 0.21, p = 0.020) while CDMI was higher (median 5 vs 1, p = 0.04). In a subset of 12 patients with faecal calprotectin within 3 months of MR enterography, correlation with motility was r = − 0.27 (p = 0.4).

Conclusions

Quantified terminal ileum motility decreases with increasing histopathological abnormality in children with Crohn disease, reproducing findings in adults. TI motility showed a negative correlation with an MRI activity score but not with faecal calprotectin levels.

Key Points

• It is feasible to perform MRI quantified bowel motility assessment in children using free-breathing techniques.

• Bowel motility in children with Crohn disease decreases as the extent of intestinal inflammation increases.

• Quantified intestinal motility may be a candidate biomarker for treatment efficacy in children with Crohn disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

a.u.:

Arbitrary units

CDMI:

Crohn Disease MRI Index

CRP:

C-reactive protein

DRAM:

Dual Registration of Abdominal Motion

eAIS:

Endoscopic Acute Inflammatory Score

IBD:

Inflammatory bowel disease

IQR:

Interquartile range

MEGS:

Magnetic Resonance Enterography Global Score

PACS:

Picture Archiving and Communication System

SD:

Standard deviation

SSFSE:

Steady-state fast spin echo

TI:

Terminal ileum

TNF:

Tumour necrosis factor

References

  1. Menys A, Atkinson D, Odille F et al (2012) Quantified terminal ileal motility during MR enterography as a potential biomarker of Crohn’s disease activity: a preliminary study. Eur Radiol 22:2494–2501

    Article  Google Scholar 

  2. Bickelhaupt S, Froehlich JM, Cattin R et al (2014) Software-assisted small bowel motility analysis using free-breathing MRI: feasibility study. J Magn Reson Imaging 39(1):17–23

    Article  Google Scholar 

  3. Cullmann JL, Bickelhaupt S, Froehlich JM et al (2013) MR imaging in Crohn’s disease: correlation of MR motility measurement with histopathology in the terminal ileum. Neurogastroenterol Motil 25:749–e577

    Article  CAS  Google Scholar 

  4. Menys A, Puylaert C, Tutein Nolthenius CE et al (2018) Quantified terminal ileal motility during MR enterography as a biomarker of Crohn disease activity: prospective multi-institution study. Radiology 289:428–435

    Article  Google Scholar 

  5. Plumb AA, Menys A, Russo E et al (2015) Magnetic resonance imaging-quantified small bowel motility is a sensitive marker of response to medical therapy in Crohn’s disease. Aliment Pharmacol Ther 42:343–355

    Article  CAS  Google Scholar 

  6. Puylaert CAJ, Nolthenius CJT, Tielbeek JAW et al (2019) Comparison of MRI activity scoring systems and features for the terminal ileum in patients with Crohn disease. AJR Am J Roentgenol 212(2):W25–W31

    Article  Google Scholar 

  7. Vernier-Massouille G, Balde M, Salleron J et al (2008) Natural history of pediatric Crohn’s disease: a population-based cohort study. Gastroenterology 135:1106–1113

    Article  Google Scholar 

  8. Van Limbergen J, Russell RK, Drummond HE et al (2008) Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 135:1114–1122

    Article  Google Scholar 

  9. Dubron C, Avni F, Boutry N, Turck D, Duhamel A, Amzallag-Bellenger E (2016) Prospective evaluation of free-breathing diffusion-weighted imaging for the detection of inflammatory bowel disease with MR enterography in childhood population. Br J Radiol 89:20150840

  10. Menys A, Hamy V, Makanyanga J et al (2014) Dual registration of abdominal motion for motility assessment in free-breathing data sets acquired using dynamic MRI. Phys Med Biol 59:4603–4619

    Article  CAS  Google Scholar 

  11. Barber JL, Zambrano-Perez A, Olsen ØE et al (2018) Detecting inflammation in inflammatory bowel disease — how does ultrasound compare to magnetic resonance enterography using standardised scoring systems? Pediatr Radiol 48(6):843–851

    Article  Google Scholar 

  12. Odille F, Menys A, Ahmed A et al (2012) Quantitative assessment of small bowel motility by nonrigid registration of dynamic MR images. Magn Reson Med 68:783–793

    Article  Google Scholar 

  13. Stange EF, Travis SPL, Vermeire S et al (2006) European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut 55(Suppl 1):i1–i15

    Article  Google Scholar 

  14. Steward MJ, Punwani S, Proctor I et al (2012) Non-perforating small bowel Crohn’s disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol 81(9):2080–2088

    Article  Google Scholar 

  15. Berni Canani R, Terrin G, Rapacciuolo L et al (2008) Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Dig Liver Dis 40(7):547–553

    Article  Google Scholar 

  16. Robin X, Turck N, Hainard A et al (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. https://doi.org/10.1186/1471-2105-12-77

  17. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845

    Article  CAS  Google Scholar 

  18. Sun X, Xu W (2014) Fast implementation of DeLong’s algorithm for comparing the areas under correlated receiver operating characteristic curves. IEEE Signal Process Lett 21(11):1389–1393

    Article  Google Scholar 

  19. Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979(86):420–428

    Article  Google Scholar 

  20. Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 327(8476):307–310

    Article  Google Scholar 

  21. Datta D, Love J (2017) Blandr: a Bland-Altman method comparison package for R. Zenodo. https://doi.org/10.5281/zenodo.824514

  22. Zou KH, Hall WJ, Shapiro DE (1997) Smooth non-parametric receiver operating characteristic (ROC) curves for continuous diagnostic tests. Stat Med 16:2143–2156

    Article  CAS  Google Scholar 

  23. Bithell J, Carpenter J (2000) Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med 19:1141–1164

    Article  Google Scholar 

  24. Menys A, Taylor SA, Emmanuel A et al (2013) Global small bowel motility: assessment with dynamic MR imaging. Radiology 269:443–450

    Article  Google Scholar 

  25. Menys A, Makanyanga J, Plumb A et al (2016) Aberrant motility in unaffected small bowel is linked to inflammatory burden and patient symptoms in Crohn’s disease. Inflamm Bowel Dis 22(2):424–432

    Article  Google Scholar 

  26. Gollifer RM, Menys A, Makanyanga J et al (2018) Relationship between MRI quantified small bowel motility and abdominal symptoms in Crohn’s disease patients-a validation study. Br J Radiol 91:20170914

    Article  Google Scholar 

  27. Makanyanga JC, Pendsé D, Dikaios N et al (2014) Evaluation of Crohn’s disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin. Eur Radiol Eur Radiol 24:277–287

    Article  Google Scholar 

  28. Bickelhaupt S, Pazahr S, Chuck N et al (2013) Crohn’s disease: small bowel motility impairment correlates with inflammatory-related markers C-reactive protein and calprotectin. Neurogastroenterol Motil 25(6):467–e363

    Article  CAS  Google Scholar 

  29. Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D (2014) High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 270:834–841

Download references

Acknowledgements

Motilent provided the GIQuant software free of charge for purposes of this study. The Centre for Medical Imaging, University College London, provided statistical support via HF and AM. This research project was supported by researchers (SAT) at the National Institute for Health Research University College London Hospitals Biomedical Research Centre.

Funding

The authors state that this work has not received any direct funding. SAT receives funding from the National Institute for Health Research University College London Hospitals Biomedical Research Centre. HF is funded by the Biotechnology and Biological Sciences Research Council (BBSRC) London Interdisciplinary Doctoral (LIDo) Consortium [BB/M009513/1] and receives funding from Motilent as part of an industrial placement.

Author information

Authors and Affiliations

Authors

Contributions

LC: collected and analysed clinical and histopathology data, and reviewed and edited the final manuscript

HF: provided statistical analysis and created all graphs and statistical diagrams, and reviewed and edited the final manuscript

AM: image analysis with TW and statistical analysis; reviewed and edited the early and final versions of the manuscript

TG: image analysis and reviewed and edited the final copy of the manuscript

SK: radiological data collection and analysis; reviewed and edited the final version of the manuscript

FK: clinical data collection; reviewed and edited the final version of the manuscript

DR and LP: histopathology data analysis; reviewed and edited the final version of the manuscript

SAT: supervised data analysis; reviewed and edited all versions of the manuscript including the final version

TW: corresponding author. TW supervised data collection, analysed the motility data, performed the MRI activity scoring, and prepared the final manuscript for publication

Corresponding author

Correspondence to Tom A. Watson.

Ethics declarations

Guarantor

The scientific guarantor of this publication is:

Professor Stuart Taylor, NIHR Senior Investigator and Consultant Radiologist, University College London, Centre for Medical Imaging.

Conflict of interest

The authors of this manuscript declare relationships with the following companies:

AM—CEO, Motilent

SAT—Motilent shareholder and paid consultant for Robarts

HF—funded for her PhD and for her industrial placement at Motilent by the Biotechnology and Biological Sciences Research Council (BBSRC) London Interdisciplinary Doctoral (LIDo) Consortium [BB/M009513/1]. She has received funding from Motilent to cover travel expenses to conferences as part of her industrial placement. She has had free use of Motilent GIQuant during her PhD.

The remaining authors declare no relevant conflicts of interest.

Statistics and biometry

Two of the authors have significant statistical expertise (HF and AM).

Informed consent

Written informed consent was waived by the Institutional Review Board. R&D Reference number 18BB10.

Ethical approval

Institutional Review Board approval was obtained. REC number 10/H0720/91GOSH.

Methodology

• retrospective

• cross-sectional study

• performed at one institution

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cococcioni, L., Fitzke, H., Menys, A. et al. Quantitative assessment of terminal ileum motility on MR enterography in Crohn disease: a feasibility study in children. Eur Radiol 31, 775–784 (2021). https://doi.org/10.1007/s00330-020-07084-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-020-07084-1

Keywords

Navigation